XML 27 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Note 11 - Stock-based Compensation
9 Months Ended
Sep. 30, 2020
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
11.
Stock-Based Compensation
 
The Company records stock-based compensation expense during the requisite service period for share-based payment awards granted to employees and non-employees.
 
The following table sets forth the Company's stock-based compensation expense (in thousands) for the periods indicated:
 
   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
   
2020
   
2019
   
2020
   
2019
 
Restricted stock
                               
Research and development
  $
142
    $
68
    $
353
    $
129
 
Selling, general and administrative    
500
     
236
     
1,122
     
581
 
                                 
Stock appreciation rights                                
Research and development    
16
     
132
     
(61
)    
114
 
Selling, general and administrative
   
16
     
132
     
(67
)    
114
 
                                 
Total stock-based compensation
  $
674
    $
568
    $
1,347
    $
938
 
 
Stock Option Award Activity
. Stock option activity under the Company's stock incentive plans at
September 30, 2020
and changes during the
three
months ended
September 30, 2020
were as follows:
 
 
 
 
 
 
 
 
 
 
 
Weighted-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average
 
 
 
 
 
 
 
 
 
 
 
Weighted-
 
 
Remaining
 
 
 
 
 
 
 
 
 
 
 
Average
 
 
Contractual
 
 
Aggregate
 
 
 
Number of
 
 
Exercise
 
 
Term
 
 
Intrinsic
 
 
 
Options
 
 
Price (1)
 
 
(years)
 
 
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at December 31, 2019
 
 
1,561
 
 
$
928.79
 
 
 
6.56
 
 
$
 
Granted
 
 
 
 
$
 
 
 
 
 
 
 
 
 
Canceled or forfeited
 
 
(9
)
 
$
72,891.04
 
 
 
 
 
 
 
 
 
Exercised
 
 
 
 
$
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at September 30, 2020
 
 
1,552
 
 
$
556.13
 
 
 
5.83
 
 
$
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options exercisable at September 30, 2020
 
 
1,552
 
 
$
556.13
 
 
 
5.83
 
 
$
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options vested and expected to vest at September 30, 2020
 
 
1,552
 
 
$
556.13
 
 
 
5.83
 
 
$
 
 
(
1
)  Exercise price of options outstanding range from
$20.00
to
$99,300.00
as of
September 30, 2020.
 
Restricted Stock
. Non-vested restricted stock awards at
September 30, 2020
and changes during the
three
months ended
September 30, 2020
were as follows:
 
 
 
 
 
 
 
Weighted-
 
 
 
 
 
 
 
Average
 
 
 
Number of
 
 
Grant-Date
 
 
 
Shares
 
 
Fair Value
 
 
 
 
 
 
 
 
 
 
Non-vested at December 31, 2019
 
 
1,308,613
 
 
$
1.91
 
Granted
 
 
4,454,046
 
 
$
0.63
 
Vested
 
 
(1,015,336
)
 
$
1.47
 
Canceled or forfeited
 
 
(6,974
)
 
$
1.90
 
 
 
 
 
 
 
 
 
 
Non-vested at September 30, 2020
 
 
4,740,349
 
 
$
0.80
 
 
The total fair value of restricted stock that vested during the
nine
months ended
September 30, 2020
totaled
$1.5
 million. As of
September 30, 2020,
the total unrecognized compensation expense, net of estimated forfeitures, relating to restricted stock awards was
$3.1
 million, which is expected to be recognized over the remaining weighted-average period of approximately
1.6
 years.